- GlobeNewswire•3 days agoRepligen To Report Fourth Quarter and Full Year 2016 Financial Results, Provides Financial Guidance for 2017
WALTHAM, Mass., Feb. 16, 2017-- Repligen Corporation today announced that the Company will report fourth quarter and full year 2016 financial results on Wednesday, February 22, 2017. The Company will issue ...
- Zacks•2 months agoThe Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin Pharmaceutical and Repligen
The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin Pharmaceutical and Repligen
- GlobeNewswire•2 months ago
WALTHAM, Mass., Jan. 04, 2017-- Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, today announced that it will present at the 35 th Annual J.P. Morgan Healthcare ...
RGEN : Summary for Repligen Corporation - Yahoo Finance
Repligen Corporation (RGEN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||30.52 - 31.15|
|52 Week Range||21.11 - 34.06|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||149.86|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|